HOUSTON and LONDON, April 22, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR) announced today that the Baker Hughes Board of Directors declared a quarterly cash dividend of $0.23 per share of ...

Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participate in ...

Integration of clinical and patient-reported outcomes expected to further differentiate EluPro’s utility in cardiac implantable electronic ...

Conventional treatment protocols involve molar extraction, followed by months of healing before an implant can be placed. The ...

Elutia (ELUT) announced the initiation of an EluPro clinical study designed to collect patient outcome data in real-world clinical practice.

Short interest in Elutia Inc (NASDAQ:ELUT) increased during the last reporting period, rising from 47.25K to 65.03K. This put 0.25% of the company's publicly available shares short. Short interest ...